Avantor
AVTR
Market cap $16.3B

24.03 USD

-0.46

1.88%

Updated Oct 22, 10:48 AM EDT

1 day

-1.88%

5 days

-2.99%

1 month

-9.59%

3 months

13.94%

6 months

-1.56%

Year to date

5.63%

1 year

16.88%

5 years

72.63%

About: Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Employees: 14,500

Industrials Laboratory Analytical Instruments

0

Funds holding %

of 6,740 funds

0

Analysts bullish %

of 9 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

11% more repeat investments, than reductions

Existing positions increased: 187 | Existing positions reduced: 168

4% more funds holding

Funds holding: 481 [Q1] → 500 (+19) [Q2]

1.44% more ownership

Funds ownership: 94.24% [Q1] → 95.68% (+1.44%) [Q2]

16% less capital invested

Capital invested by funds: $16.3B [Q1] → $13.8B (-$2.56B) [Q2]

29% less funds holding in top 10

Funds holding in top 10: 14 [Q1] → 10 (-4) [Q2]

33% less call options, than puts

Call options by funds: $95.7M | Put options by funds: $143M

See Fund Rankings

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$27

12%

upside

Avg. target

$30

23%

upside

High target

$34

41%

upside

9 analyst ratings

9 positive

100%

0 neutral

0%

0 negative

0%

UBS Daniel Brennan 80% 1-year accuracy 4 / 5 met price target	21%upside $29	Buy Maintained	8 Oct 2024
RBC Capital Conor McNamara 52% 1-year accuracy 11 / 21 met price target	41%upside $34	Outperform Reiterated	26 Sept 2024
Wells Fargo Brandon Couillard 50% 1-year accuracy 6 / 12 met price target	25%upside $30	Overweight Initiated	27 Aug 2024
TD Cowen Dan Brennan 67% 1-year accuracy 18 / 27 met price target	29%upside $31	Buy Maintained	29 Jul 2024
Morgan Stanley Tejas Savant 55% 1-year accuracy 6 / 11 met price target	21%upside $29	Overweight Maintained	29 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 8 articles about AVTR published over the past 30 days

Zacks Investment Research

AVTR Stock Flat Following the Close of Divestiture Deal With Audax

Avantor closes its deal with Audax to divest its clinical services business.

AVTR Stock Flat Following the Close of Divestiture Deal With Audax

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with the employees, has re-branded the business as Resonant Clinical Solutions (“Resonant” or “the Company”). Resonant is comprised of three well-respected brands – EPL Archives, MESM, and Therapak. These long-standing brands, whose roots and lineage extend as far back as the 1970s, provide a comprehensi.

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax Private Equity in a transaction valued at approximately $650 million.

Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

Zacks Investment Research

MD vs. AVTR: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?

MD vs. AVTR: Which Stock Should Value Investors Buy Now?

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management

Recognition highlights commitment to Avantor Business System (ABS) principles to enhance customer experience RADNOR, Pa. , Sept. 30, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today that the Company's NuSil brand has received the 2024 North American Daily Kaizen Management award from the Kaizen Institute.

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

RADNOR, Pa. , Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2024 financial results before the market opens on Friday, October 25, and will hold a conference call on the same day at 8:00 a.m.

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy annually beginning in 2026 Avantor continues to implement global solar installations, with more planned in 2025 RADNOR, Pa. , Sept. 25, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has entered into a 10-year virtual power purchase agreement through the Energize program, a first of its kind initiative to increase access to renewable energy for pharmaceutical supply chains.

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

RADNOR, Pa. , Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at BioProcess International 2024, scheduled for September 23-26 in Boston.

Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Broyhill's Q2 2024 Top Five Investments

Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July after a strong earnings report, reaffirming full-year guidance and showing signs of industry recovery. Baxter's shares increased significantly post-earnings, demonstrating portfolio durability and organic growth, prompting us to accumulate shares at attractive valuations.

Broyhill's Q2 2024 Top Five Investments

Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance

EcoVadis Rating validates Avantor's business sustainability commitments and performance RADNOR, Pa. , Sept. 12, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today, for the second year in a row, that the Company has been awarded a Bronze Medal from EcoVadis, a global leader in business sustainability assessments.

Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance

See News Rankings

Charts implemented using Lightweight Charts™